Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy
- 31 May 1998
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 22 (5) , 465-472
- https://doi.org/10.1016/s0145-2126(98)00016-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Results of treatment with an intensive induction regimen using idarubicin in combination with cytarabine and etoposide in children with acute myeloblastic leukemiaLeukemia Research, 1996
- Erythroblastic and/or Megakaryoblastic Leukemia in Down SyndromeJournal of Pediatric Hematology/Oncology, 1996
- The Treatment of Children with Acute Megakaryoblastic Leukemia Who Have Down SyndromeJournal of Pediatric Hematology/Oncology, 1996
- Transient myeloproliferative disorder associated with trisomy 21, a wide range syndrome: Report of two cases with trisomy 21 mosaicismMedical and Pediatric Oncology, 1995
- Monoclonal nature of transient abnormal myelopoiesis in Down's syndromeBlood, 1991
- Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndromeBlood, 1988
- Transient myeloproliferative disorder and acute nonlymphoblastic leukemia in Down syndromeThe Journal of Pediatrics, 1988
- Megakaryoblastic Leukemia and Down's Syndrome: A ReviewPediatric Hematology and Oncology, 1987
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958